Cancer Treatment

Oct 11, 2023

Harnessing the Power of Immunomodulators: Applications and Implications

Jun 02, 2023

Antibody-drug Conjugates in Oncology: An Overview of the Current and Future Treatment Landscape

May 03, 2023

Cancer Diagnostic Market: Evaluating the Major Growth Factors and the Key Developments in the Domain

Mar 17, 2023

Immuno-Oncology (I-O) Therapeutics: The Key to Future Cancer Treatment

Mar 13, 2023

Cancer Biomarkers: Improving Treatment and Detection

Feb 27, 2023

Minimal Residual Disease (MRD) Testing: A Path to Cure Cancer?

Feb 24, 2023

Top 10 Expected Oncology Drug Launches in 2023

Jan 12, 2023

Vivos Therapeutics ‘s DNA Oral Appliance for the Treatment of OSA; Arthrex’s TightRope Implant for Pediatric ACL Surgery; Chindex Medical Acquired 10 ViewRay MRIdian Systems; Zimmer Biomet to Acquire Embody; GE HealthCare to buy IMACTIS; Glaukos Announced the iDose TR Exchange Trial

Jan 02, 2023

ENHERTU’s Journey in Cancer Treatment and Management

Dec 16, 2022

ASH 2022: Roche’s Polivy vs ADC Therapeutics’ Zynlonta, Antibody-Drug Conjugates (ADC) in R/R DLBCL

Newsletter/Whitepaper